Jim Cramer and Jeff Marks, the Club’s director of portfolio analysis, ran through all 30 holdings in the portfolio during the June Monthly Meeting on Wednesday. Here’s a rapid fire update on each stock, starting with those that Jim and Jeff said investors should consider trimming — or that the Club has sold recently — as uncertainty over President Donald Trump’s tariffs and the conflict in the Middle East linger. Abbott Laboratories : One of our best stocks of the year, Abbott got more good news Tuesday when HHS chief Robert F. Kennedy Jr. talked up wearable health products. Abbott’s continuous glucose monitors fit the bill. In fact, the stock’s had such a good run, we’d consider taking some off. Broadcom : The chipmaker’s incredible rally off its April lows has made the stock one of our biggest positions. While we may need to book more profits, there’s no doubt its AI business is doing incredibly well. CrowdStrike : We just trimmed the stock Tuesday and now we can let it run. Up 40% this year, it trails only recent addition GE Vernova on our portfolio leaderboard. Cybersecurity spending is a must-have for companies, and CrowdStrike continues to put last year’s IT outage behind it. Disney: We battled Disney and won. Instead of taking a bow, our discipline calls for us to take some off the table. We still like the stock, though, and its strong quarter last month provided plenty to like. Eaton: The Club also offloaded shares of this industrial name Tuesday, noting the stock could tumble as tariff uncertainty looms and due to Wall Street’s reductionist view that Eaton’s solely a data center play. It’s more than that to us though. In fact, management announced its acquisition of aerospace and defense company Ultra Precision Control Systems last week. “What a great move that was,” Jim said. Wells Fargo: We’re mulling a sale of this bank stock, too. Wells Fargo’s position has ballooned in our portfolio. It’s currently the fourth largest among our 30 holdings. Management is expected to announce buybacks late Friday following the Fed’s annual stress tests results. We’re hoping to take some off and book profits in the following session. Updates on the other 24 Apple: This tech behemoth continues to be an issue for us. Apple needs to stop buying back so much stock and focus on its generative artificial intelligence efforts. The iPhone maker’s best bet is to acquire startup Perplexity AI, which could give Apple more AI talent and technology. This follows media reports last week that management was considering an outright buy or partnering with Perplexity. Amazon: Somehow, all three of its main businesses — retail, cloud and advertising — are firing on all cylinders and yet the stock is down 3% for the year. Jim said it’s worth buying here, but advised leaving room to buy more later because the stock can be volatile. BlackRock : This stock has been “stuck in the mud,” according to Jim. It’s tempting to sell because of its muted share performance, but we’re holding out hope. After all, BlackRock’s still a quality asset manager with great underlying fundamentals. Management announced a series of acquisitions in private markets over the past year that make it even more attractive. Bristol Myers Squibb : It’s pretty simple here: The drugmaker needs to get its act together on schizophrenia treatment Cobenfy, or else we’re going to move on. We’re expecting results later this year looking at the drug’s ability to treat Alzheimer’s psychosis. Capital One: This is one of Jim’s favorite names in the portfolio right now. The financial stock should be up even more after its completed $35 billion acquisition of Discover Financial. After all, Capital one will soon grab more share in the credit card market not only in the United States, but internationally, too. Costco: Retailers aren’t out of the tariff woods just yet, but Costco will be able to stay above the fray. Remember, its membership dues are its key source of profits, not the merch it sells. Salesforce: The stock has become a quandary. While it’s tempting to say ring the register, the software maker’s annual Dreamforce conference in September should give us a better idea of where its AI product Agentforce is going. Coterra Energy: This has been our geopolitical hedge, coupled with great flexibility on oil and natural gas production. We’d look to add more below $24 a share. DuPont: This stock has lagged significantly since the start of 2025. The chemical maker’s exposure to China poses a real risk for investors. We’re hoping that its forthcoming spinoff will improve investor sentiment. That’s why the Club’s staying in DuPont for now. Danaher: Its China business has been a problem, and so has its management. Jim said he’s reluctant to exit the position out of fear that the company will eventually replace the CEO and send the stock much higher. Dover: This AI industrial play is undervalued by Wall Street. If the stock falls more, the Club would consider buying additional shares. After all, Dover has amazing earnings growth potential, and its exposure to the data center buildout craze makes it even more attractive. GE Vernova: The stock is one of the most compelling stories in the market due to the AI data center buildout. Additionally, as companies look to build compute infrastructure, ordering their turbines will lower the trade surplus. We’re waiting for shares to go down again before buying more. Goldman Sachs: Shares can still go up once the IPO boom really takes off. As more and more companies go public, they will turn to Goldman’s first-class investment banking services. This will boost revenues for a crucial line of business for the Wall Street bank. Home Depot: Once the Federal Reserve lowers interest rates, Jim said the home improvement retailer’s stock could climb much higher. That’s because Home Depot is a key beneficiary of a turnaround in the housing market, which typically improves as borrowing costs go down. This stock has been a real dog, but we’re still believers — for now. Honeywell International: It’s no secret: Honeywell shares have underperformed industrial peers in 2025. We’re not concerned about the stock yet though. Honeywell’s forthcoming split into three publicly traded companies should push shares much higher. Jim said it could be the next GE, which successfully spun off two of its businesses last year. Linde: We’re sitting tight in this stock. The industrial gas giant has quality fundamentals and a track record of delivering for shareholders despite its recent muted performance. Eli Lilly: The drug stocks have generally been difficult to own this year, but if there’s only one you could own, it would be Lilly. It has the best injectable GLP-1 on the market and it has an oral obesity pill poised to hit the U.S. market next year. Meta Platforms: Don’t buy Meta at current levels. If there’s a material pullback without a major change to the thesis, however, that would be a different story. CEO Mark Zuckerberg’s aggressive moves to bring in AI talent show his commitment to the technology. Microsoft: We’re remaining long on this Big Tech name. After all, Microsoft’s finally showing the payoff of its AI investments. In April, the company posted better-than-expected quarterly earnings, highlighted by accelerating revenue growth in its cloud computing business. Nvidia: The AI chip king is on pace for a record close Wednesday. While there are concerns that the custom chip efforts of megacap tech companies could infringe on Nvidia’s dominance, we don’t see the market as a winner-take-all situation. Demand for AI computing remains fervent. Palo Alto Networks: We remain bullish on the stock. Cybersecurity is a great sector to be in because companies continue to allocate part of their budgets to these services regardless of the macro backdrop. Like CrowdStrike, Jim forecasts that Palo Alto will grab more market share from its peers because of the quality of its offerings. Starbucks: For new Club members, Jim said he’d buy a little stock at current levels and then a little more if it falls to $85 a share. Despite all its challenges in China, we’re pleased that there’s multiple parties interested in that business. TJX Companies : The stock has pulled back from where it was before earnings on May 21, which Jim said is an opportunity for investors to buy some stock and potentially more if it drops to $120. Like Costco, this is a retailer that can actually benefit from tariffs. Texas Roadhouse: Shares are worth buying now, Jim said, because there’s no guarantee that the stock will get dinged on non-fundamental concerns like it did earlier this year around weather. The restaurant operator is all about value and a fun dining experience. (See here for a full list of the stocks in Jim Cramer’s Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
www.cnbc.com
#stocks #trim #big #runs #updates #rest #portfolio
